These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 3398734)

  • 1. Isointense model for the evaluation of tumor-specific MRI contrast agents.
    Button TM; Fiel RJ
    Magn Reson Imaging; 1988; 6(3):275-80. PubMed ID: 3398734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metalloporphyrin contrast enhancement of tumors in magnetic resonance imaging. A study of human carcinoma, lymphoma, and fibrosarcoma in mice.
    Ogan MD; Revel D; Brasch RC
    Invest Radiol; 1987 Oct; 22(10):822-8. PubMed ID: 3429177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proton relaxation enhancement by manganese(III)TPPS4 in a model tumor system.
    Fiel RJ; Button TM; Gilani S; Mark EH; Musser DA; Henkelman RM; Bronskill MJ; van Heteren JG
    Magn Reson Imaging; 1987; 5(2):149-56. PubMed ID: 3586881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Mn-TPPS4 in the diagnosis of malignant skin tumors. In vivo studies with high resolution magnetic resonance tomography in melanotic melanoma].
    Mäurer J; Strauss A; Ebert W; Bauer H; Schroeder RJ; Felix R
    Radiologe; 1999 May; 39(5):422-7. PubMed ID: 10384698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Mn-TPPS4; a potential MRI contrast agent for localizing the normal aortic wall in rabbits].
    Kim SW; Kozuka T
    Nihon Igaku Hoshasen Gakkai Zasshi; 1990 Feb; 50(2):192-4. PubMed ID: 2362799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mn-porphyrins as novel molecular magnetic resonance imaging contrast agents.
    Mouraviev V; Venkatraman TN; Tovmasyan A; Kimura M; Tsivian M; Mouravieva V; Polascik TJ; Wang H; Amrhein TJ; Batinic-Haberle I; Lascola C
    J Endourol; 2011 Nov; ():1420-4. PubMed ID: 22050509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contrast-enhanced high resolution magnetic resonance imaging of pigmented malignant melanoma using Mn-TPPS4 and Gd-DTPA: experimental results.
    Mäurer J; Strauss A; Ebert W; Bauer H; Felix R
    Melanoma Res; 2000 Feb; 10(1):40-6. PubMed ID: 10711639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Magnetic resonance imaging-histomorphologic correlation studies on paramagnetic metalloporphyrins in rat models of necrosis.
    Ni Y; Petré C; Miao Y; Yu J; Cresens E; Adriaens P; Bosmans H; Semmler W; Baert AL; Marchal G
    Invest Radiol; 1997 Dec; 32(12):770-9. PubMed ID: 9406018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. P03277-A New Approach to Achieve High-Contrast Enhancement: Initial Results of an Experimental Extracellular Gadolinium-Based Magnetic Resonance Contrast Agent.
    Fries P; Müller A; Seidel R; Robert P; Denda G; Menger MD; Schneider G; Buecker A
    Invest Radiol; 2015 Dec; 50(12):835-42. PubMed ID: 26186281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioinspired, Manganese-Chelated Alginate-Polydopamine Nanomaterials for Efficient in Vivo T
    Addisu KD; Hailemeskel BZ; Mekuria SL; Andrgie AT; Lin YC; Tsai HC
    ACS Appl Mater Interfaces; 2018 Feb; 10(6):5147-5160. PubMed ID: 29277987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatic contrast-enhancing properties of manganese-mesoporphyrin and manganese-TPPS4. A comparative magnetic resonance imaging study in rats.
    Schmiedl UP; Nelson JA; Starr FL; Schmidt R
    Invest Radiol; 1992 Jul; 27(7):536-42. PubMed ID: 1644554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of Motexafin gadolinium (MGd) as a contrast agent for intraoperative MRI.
    Hirschberg H; Wu GN; Madsen SJ
    Minim Invasive Neurosurg; 2007 Dec; 50(6):318-23. PubMed ID: 18210352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metalloporphyrin magnetic resonance contrast agents. Feasibility of tumor-specific magnetic resonance imaging.
    van Zijl PC; Place DA; Cohen JS; Faustino PJ; Lyon RC; Patronas NJ
    Acta Radiol Suppl; 1990; 374():75-9. PubMed ID: 1966973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tissue distribution and stability of metalloporphyrin MRI contrast agents.
    Lyon RC; Faustino PJ; Cohen JS; Katz A; Mornex F; Colcher D; Baglin C; Koenig SH; Hambright P
    Magn Reson Med; 1987 Jan; 4(1):24-33. PubMed ID: 3821476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative magnetic resonance imaging of rat brain tumors: in vivo NMR relaxometry for the discrimination of normal and pathological tissues.
    Hoehn-Berlage M; Bockhorst K
    Technol Health Care; 1994 Dec; 2(4):247-54. PubMed ID: 7842309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preclinical evaluation of gadolinium (III) texaphyrin complex. A new paramagnetic contrast agent for magnetic resonance imaging.
    Young SW; Sidhu MK; Qing F; Muller HH; Neuder M; Zanassi G; Mody TD; Hemmi G; Dow W; Mutch JD
    Invest Radiol; 1994 Mar; 29(3):330-8. PubMed ID: 8175308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Specific and non-specific contrast media for MRI of tumors. Experimental study of human breast carcinoma].
    Revel D; Ogan M; Paajanen H; Grodd W; Couet W; Rosenau W; Brasch RC
    J Radiol; 1989 Feb; 70(2):115-21. PubMed ID: 2715972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gadolinium-free T1 contrast agents for MRI: tunable pharmacokinetics of a new class of manganese porphyrins.
    Cheng HL; Haedicke IE; Cheng W; Tchouala Nofiele J; Zhang XA
    J Magn Reson Imaging; 2014 Dec; 40(6):1474-80. PubMed ID: 24214904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimization of pulse sequences in magnetic resonance lymphography of axillary lymph nodes using magnetic nanoparticles.
    Gharehaghaji N; Oghabian MA; Sarkar S; Amirmohseni S; Ghanaati H
    J Nanosci Nanotechnol; 2009 Jul; 9(7):4448-52. PubMed ID: 19916472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brain tumor enhancement in magnetic resonance imaging at 3 tesla: intraindividual comparison of two high relaxivity macromolecular contrast media with a standard extracellular gd-chelate in a rat brain tumor model.
    Fries P; Runge VM; Bücker A; Schürholz H; Reith W; Robert P; Jackson C; Lanz T; Schneider G
    Invest Radiol; 2009 Apr; 44(4):200-6. PubMed ID: 19300099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.